December 10, 2021 Experience CANbridge Pharmaceuticals HK$685 million IPO We advised CANbridge Pharmaceuticals on its IPO and HKEX listing
December 10, 2021 Experience Merck $8 billion notes offering, including its debut sustainability debt The offering includes five tranches of notes
December 8, 2021 Experience Olympus $500 million senior notes offering The debut offering consisted of 2.143% senior notes due 2026
November 24, 2021 Experience Privia Health $174 million secondary offering We advised Privia on its SEC-registered offering of stock
November 23, 2021 Experience Alignment Healthcare $193 million SEC-registered secondary offering The shares are listed on the Nasdaq Global Select Market
November 15, 2021 Experience Apria $141.7 million secondary offering The shares are listed on the Nasdaq Global Select Market
November 15, 2021 Experience Revolution Medicines $250 million at-the-market offering The shares are listed on the Nasdaq Global Select Market
November 12, 2021 Experience Affimed $100 million at-the-market offering The shares are listed on the Nasdaq Global Market
November 12, 2021 Experience Cryoport $403 million notes offering and concurrent $249 million stock offering The company issued 0.75% convertible senior notes due 2026 and sold shares in a registered direct offering